s6y
Company name or ticker
Search
Acer Therapeutics Inc.
DEF 14A
Definitive proxy statements
Filed
Wednesday, October 14, 2020
Period
Nov 19, 2020
Accession number
0001193125-20-269199
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header